BRPI0703127A2 - composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia - Google Patents
composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhiaInfo
- Publication number
- BRPI0703127A2 BRPI0703127A2 BRPI0703127-0A BRPI0703127A BRPI0703127A2 BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2 BR PI0703127 A BRPI0703127 A BR PI0703127A BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2
- Authority
- BR
- Brazil
- Prior art keywords
- spp
- bacteria
- acute
- treatment
- caused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIçãO PARA O TRATAMENTO DE OTITES AGUDAS OU CRÈNICAS CAUSADAS POR FUNGOS E/OU BACTéRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova associação composta por um antibiótico da classe das quinolonas, denominado Ciprofloxacina; um antifúngico azólico - Cetoconazol; um antiinflamatório corticóide - Fluocinolona e um anestésico local da classe das aminas - Lidocaína, destinada para o tratamento das otites agudas ou crónicas em animais de companhia, particularmente cães e gatos, causadas por bactérias: Staphylococcus intermedius, Staphylococcus aureus, Staphylococcus spp, Streptococcus spp, Streptococcus pyo genes, Proteus mirabilis, Proteus vulgaris, Proteus spp, Pseudomonas aeruginosa, Escherichia coli, Corynebacterium spp e demais bactérias. Fungos. Mailassezia pachydermatis (Pityrosporum canis), Epidermophyton floccosum, Microsporum canis, Trichophyton rubrum, Trichophyton mentagrophytes, Candida spp entre outros.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
US12/671,750 US20110275602A1 (en) | 2007-08-22 | 2008-08-18 | Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
PCT/BR2008/000248 WO2009023943A1 (en) | 2007-08-22 | 2008-08-18 | Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0703127A2 true BRPI0703127A2 (pt) | 2009-04-14 |
Family
ID=40377770
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0703127-0A BRPI0703127A2 (pt) | 2007-08-22 | 2007-08-22 | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0806095-9A BRPI0806095A2 (pt) | 2007-08-22 | 2008-08-18 | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia |
Country Status (3)
Country | Link |
---|---|
US (1) | US20110275602A1 (pt) |
BR (2) | BRPI0703127A2 (pt) |
WO (1) | WO2009023943A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011076721A1 (en) | 2009-12-22 | 2011-06-30 | Deutsches Krebsforschungszentrum | Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
EP2654637A1 (en) | 2010-12-23 | 2013-10-30 | Boehringer Ingelheim Vetmedica GmbH | Kit-in-parts for cleaning and treating ears of companion animals |
WO2016157929A1 (ja) * | 2015-03-31 | 2016-10-06 | 国立研究開発法人産業技術総合研究所 | インターフェロンαの経口投与による慢性難治性外耳炎治療効果 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043251A1 (en) * | 2003-08-20 | 2005-02-24 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20070054844A1 (en) * | 2003-08-20 | 2007-03-08 | Fairfield Clinical Trials, Llc | Method for treating otitis externa |
WO2005055921A2 (en) * | 2003-12-12 | 2005-06-23 | Eran Eilat | Compositions for treatment of ear disorders and methods of use thereof |
CN101039668A (zh) * | 2004-08-13 | 2007-09-19 | 先灵-普劳有限公司 | 包含抗菌素、三唑和皮质类固醇的药物制剂 |
-
2007
- 2007-08-22 BR BRPI0703127-0A patent/BRPI0703127A2/pt not_active Application Discontinuation
-
2008
- 2008-08-18 BR BRPI0806095-9A patent/BRPI0806095A2/pt not_active Application Discontinuation
- 2008-08-18 US US12/671,750 patent/US20110275602A1/en not_active Abandoned
- 2008-08-18 WO PCT/BR2008/000248 patent/WO2009023943A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009023943A1 (en) | 2009-02-26 |
BRPI0806095A2 (pt) | 2009-11-17 |
WO2009023943A8 (en) | 2009-10-15 |
US20110275602A1 (en) | 2011-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cazoto et al. | Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis | |
Eames et al. | Microbiological analysis of epidermal growth factor receptor inhibitor therapy‐associated paronychia | |
BR112016006589A2 (pt) | composição, e composição de vacina | |
BRPI0703127A2 (pt) | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia | |
WO2020061375A8 (en) | Antibacterial compounds | |
PH12021551143A1 (en) | Novel imidazole derivative | |
May et al. | Antibacterial effect of N‐acetylcysteine on common canine otitis externa isolates | |
BR112022009880A2 (pt) | Composição de extratos naturais com atividade antibacteriana ou bacteriostática também para bactérias gram-negativas | |
BRPI0700969A (pt) | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia | |
NZ713357A (en) | Antimicrobial compounds and methods of making and using the same | |
TW201129364A (en) | Eye drop for treating eye infection disease containing levofloxacin or its salt or solvate thereof | |
Aonofriesei | Effect of methylpyrazoles and coumarin association on the growth of Gram-negative bacteria | |
Al-Salahi et al. | Antibacterial activity of newly synthesized 5-hydrazono-triazoloquinazolines | |
Detusheva et al. | Susceptibility of Nosocomial K. pneumoniae, P. aeruginosa, A. baumannii, and P. mirabilis Strains to a Chlorhexidine-Based Antiseptic Preparation | |
Anitha et al. | Efficacy of antibacterial activity of garlic cloves from Tamil Nadu and Jowai region. | |
MAMTA | Identification of Bovine Mastitis Associated Pathogens by Conventional and Mass Spectrometry Methods | |
RU2020123463A (ru) | Вакцина для профилактики мастита у крупного рогатого скота | |
DURÁN CHÁVEZ et al. | Bacterial Resistance and Sensitivity in Urine Cultures in a Women Population in Ecuador | |
Cengiz et al. | Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods | |
Pestova et al. | MICROBIAL ASSOCIATIONS IN PATIENTS WITH CHRONIC RHINOSINUSITIS | |
BR112023017203A2 (pt) | Derivado de ácido bórico que age como inibidor de beta-lactamase | |
Bajon et al. | Antibacterial activity of Sandoricum koetjape (Santol) leaf ethanolic extract against Staphylococcus aureus and Escherichia coli | |
Lindgren et al. | Eradication of MRSA throat carriage-a randomized trial comparing topical treatment with rifampicin-based systemic therapy | |
Mahmood et al. | The effect of germinated wheat extractions Triticum aestivum on some pathogenic bacterial species isolated from burns infections | |
MD4600B1 (ro) | Compus hidrazonic al acidului 4-formil-3-hidroxi-2-naftoic care manifestă activitate antimicrobiană |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11K | Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved |
Free format text: PRIORIDADE INTERNA DO PEDIDO PI 0806095-9. |
|
B03G | Publication of an application: publication cancelled [chapter 3.7 patent gazette] |
Free format text: REFERENTE A RPI 1997 DE 14/04/2009. |
|
B03F | Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette] |